Table of Contents

company-logo

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom Real-Time API, which enables invited third-party developers to integrate real-time CGM data into their digital health applications and devices; Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions; and Dexcom Share, a remote monitoring system. The company's products candidature comprises Dexcom G7, a next generation G7 CGM system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was incorporated in 1999 and is headquartered in San Diego, California.

DexCom Dividend Announcement

• DexCom does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on DexCom dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

DexCom Dividend History

DexCom Dividend Yield

DexCom current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing DexCom stock? Use our calculator to estimate your expected dividend yield:

DexCom Financial Ratios

P/E ratio44.69
PEG ratio3.92
P/B ratio15.38
ROE31.20%
Payout ratio0.00%
Current ratio2.46
Quick ratio2.12
Cash Ratio0.36

DexCom Dividend FAQ

Does DexCom stock pay dividends?
DexCom does not currently pay dividends to its shareholders.
Has DexCom ever paid a dividend?
No, DexCom has no a history of paying dividends to its shareholders. DexCom is not known for its dividend payments.
Why doesn't DexCom pay dividends?
There are several potential reasons why DexCom would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will DexCom ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While DexCom has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is DexCom a dividend aristocrat?
DexCom is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is DexCom a dividend king?
DexCom is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is DexCom a dividend stock?
No, DexCom is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy DexCom stocks?
To buy DexCom you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy DexCom stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.